(VIANEWS) – The ONE Group Hospitality (STKS), United Therapeutics Corporation (UTHR), Quanta Services (PWR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. The ONE Group Hospitality (STKS)
18.3% sales growth and 7.01% return on equity
The ONE Group Hospitality, Inc., a hospitality company, develops, owns, operates, manages, and licenses restaurants and lounges worldwide. It operates through STK, Kona Grill, and ONE Hospitality segments. The company also provides turn-key food and beverage services for hospitality venues, including hotels, casinos, and other locations. Its hospitality food and beverage solutions include developing, managing, and operating restaurants, bars, rooftops, pools, banqueting, catering, private dining rooms, room service, and mini bars; and offers hospitality advisory and consulting services. The company operates restaurants primarily under the STK and Kona Grill brands. As of December 31, 2021, it owned, operated, managed, or licensed 60 venues, including 23 STKs and 24 Kona Grills in North America, Europe, and the Middle East, as well as 13 F&B venues in seven hotels and casinos in the United States and Europe. The ONE Group Hospitality, Inc. was founded in 2004 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, The ONE Group Hospitality has a trailing twelve months EPS of $0.15.
PE Ratio
The ONE Group Hospitality has a trailing twelve months price to earnings ratio of 29.8. Meaning, the purchaser of the share is investing $29.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.01%.
Yearly Top and Bottom Value
The ONE Group Hospitality’s stock is valued at $4.47 at 19:22 EST, way under its 52-week high of $9.40 and way higher than its 52-week low of $3.94.
Earnings Before Interest, Taxes, Depreciation, and Amortization
The ONE Group Hospitality’s EBITDA is 0.94.
Sales Growth
The ONE Group Hospitality’s sales growth is 14% for the present quarter and 18.3% for the next.
2. United Therapeutics Corporation (UTHR)
16.2% sales growth and 17.52% return on equity
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Earnings Per Share
As for profitability, United Therapeutics Corporation has a trailing twelve months EPS of $18.13.
PE Ratio
United Therapeutics Corporation has a trailing twelve months price to earnings ratio of 12.38. Meaning, the purchaser of the share is investing $12.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 2.2B for the twelve trailing months.
3. Quanta Services (PWR)
15.5% sales growth and 10.93% return on equity
Quanta Services, Inc. provides specialty contracting services in the United States, Canada, Australia, Latin America, and internationally. Its Electric Power Infrastructure Services segment designs, installs, upgrades, repairs, and maintains electric power transmission and distribution infrastructure, and substation facilities, as well as provides other engineering and technical services; designs, installs, maintains, and repairs commercial and industrial wiring; and operates a postsecondary educational institution. It also offers emergency restoration services, including the repair of infrastructure damaged by inclement weather; installation, maintenance, and upgrade of electric power infrastructure; and installation of smart grid technologies on electric power networks. In addition, this segment provides services related to development of solar, wind, and various natural gas generation facilities, as well as related switchyards and transmission infrastructure; and construction of electric power generation facilities. The company's Pipeline and Industrial Infrastructure Services segment designs, installs, repairs, and maintains pipeline transmission and distribution systems, gathering systems, production systems, storage systems, and compressor and pump stations, as well as offers related trenching, directional boring, and mechanized welding services; and designs, installs, and maintains fueling systems, and water and sewer infrastructure. This segment also provides pipeline protection, integrity testing, and rehabilitation and replacement, as well as pipeline support systems, and related structures and facilities fabrication services; and high-pressure and critical-path turnaround, electrical, piping, fabrication, and storage tank services. It serves electric power, energy, and communications companies, as well as commercial, industrial, and governmental entities. The company was founded in 1997 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Quanta Services has a trailing twelve months EPS of $3.91.
PE Ratio
Quanta Services has a trailing twelve months price to earnings ratio of 42.17. Meaning, the purchaser of the share is investing $42.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.3%, now sitting on 18.35B for the twelve trailing months.
Volume
Today’s last reported volume for Quanta Services is 790830 which is 15.13% below its average volume of 931862.
Yearly Top and Bottom Value
Quanta Services’s stock is valued at $164.87 at 19:22 EST, way under its 52-week high of $212.82 and way above its 52-week low of $134.61.
Sales Growth
Quanta Services’s sales growth is 17.9% for the ongoing quarter and 15.5% for the next.
4. USA Compression Partners, LP (USAC)
15.5% sales growth and 14.3% return on equity
USA Compression Partners, LP provides natural gas compression services. The company offers compression services to oil companies and independent producers, processors, gatherers, and transporters of natural gas and crude oil, as well as operates stations. It primarily focuses on providing natural gas compression services to infrastructure applications, including centralized natural gas gathering systems and processing facilities, as well as gas lift applications for crude oil wells. As of December 31, 2022, the company had 3,716,854 horsepower in its fleet. USA Compression Partners, LP was founded in 1998 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, USA Compression Partners, LP has a trailing twelve months EPS of $0.03.
PE Ratio
USA Compression Partners, LP has a trailing twelve months price to earnings ratio of 821.67. Meaning, the purchaser of the share is investing $821.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.3%.
5. Curtiss (CW)
10.8% sales growth and 16.89% return on equity
Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power. The Commercial/Industrial segment offers industrial vehicle products, such as electronic throttle control devices, joysticks, and transmission shifters; sensors, controls and electro-mechanical actuation components used in commercial aircrafts; valves for use in the industrial markets; and surface technology services, including shot peening, laser peening, coatings, and advanced testing. The Defense segment provides commercial off-the-shelf embedded computing board-level modules, data acquisition and flight test instrumentation equipment, integrated subsystems, instrumentation and control systems, turret aiming and stabilization products, and weapons handling systems; avionics and electronics; and aircraft data management solutions to the commercial aerospace market. The Power segment offers hardware, pumps, pump seals, control rod drive mechanisms, valves, fastening systems, specialized containment doors, airlock hatches, spent fuel management products, and fluid sealing products for nuclear power plants and nuclear equipment manufacturers; and naval propulsion and auxiliary equipment, including coolant pumps, power-dense compact motors, generators, steam turbines, valves, and secondary propulsion systems, as well as ship repair and maintenance services primarily to the U.S. navy. Curtiss-Wright Corporation was founded in 1929 and is headquartered in Davidson, North Carolina.
Earnings Per Share
As for profitability, Curtiss has a trailing twelve months EPS of $8.92.
PE Ratio
Curtiss has a trailing twelve months price to earnings ratio of 23.92. Meaning, the purchaser of the share is investing $23.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.89%.
6. RenaissanceRe Hold (RNR)
9.2% sales growth and 20.84% return on equity
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. The company distributes its products and services primarily through intermediaries. It also invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.
Earnings Per Share
As for profitability, RenaissanceRe Hold has a trailing twelve months EPS of $30.48.
PE Ratio
RenaissanceRe Hold has a trailing twelve months price to earnings ratio of 6.91. Meaning, the purchaser of the share is investing $6.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.84%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 0.72%.
Volume
Today’s last reported volume for RenaissanceRe Hold is 167173 which is 58.79% below its average volume of 405667.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 165.2% and 3.7%, respectively.
7. Globus Medical (GMED)
5.9% sales growth and 11.09% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $2.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 22.83. Meaning, the purchaser of the share is investing $22.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.09%.
Sales Growth
Globus Medical’s sales growth is 5.8% for the ongoing quarter and 5.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Globus Medical’s EBITDA is 62.76.
Moving Average
Globus Medical’s value is way under its 50-day moving average of $51.85 and way under its 200-day moving average of $57.73.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 8% and 5.1%, respectively.
8. PACCAR (PCAR)
5.9% sales growth and 28.39% return on equity
PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods. It sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full-service leasing operations under the PacLease trade name, as well as provides finance and leasing products and services to customers and dealers. This segment also offers equipment financing and administrative support services for its franchisees; retail loan and leasing services for small, medium, and large commercial trucking companies, as well as independent owners/operators and other businesses; and truck inventory financing services to independent dealers. In addition, this segment offers loans and leases directly to customers for the acquisition of trucks and related equipment. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.
Earnings Per Share
As for profitability, PACCAR has a trailing twelve months EPS of $7.83.
PE Ratio
PACCAR has a trailing twelve months price to earnings ratio of 11.29. Meaning, the purchaser of the share is investing $11.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.39%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 13, 2023, the estimated forward annual dividend rate is 1.04 and the estimated forward annual dividend yield is 1.18%.
Yearly Top and Bottom Value
PACCAR’s stock is valued at $88.39 at 19:22 EST, below its 52-week high of $90.05 and way above its 52-week low of $64.33.
Earnings Before Interest, Taxes, Depreciation, and Amortization
PACCAR’s EBITDA is 1.51.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 34.18B for the twelve trailing months.
